These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35895055)

  • 1. The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma.
    Youn GM; Case AG; Jarin T; Li B; Swarup A; Naranjo A; Bou-Khalil C; Yao J; Zhou Q; Hom ME; Rosenthal EL; Wu AY
    Transl Vis Sci Technol; 2022 Jul; 11(7):23. PubMed ID: 35895055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
    Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
    Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET of EGFR antibody distribution in head and neck squamous cell carcinoma models.
    Niu G; Li Z; Xie J; Le QT; Chen X
    J Nucl Med; 2009 Jul; 50(7):1116-23. PubMed ID: 19525473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
    Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
    Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab.
    Liu Z; Liu Y; Jia B; Zhao H; Jin X; Li F; Chen X; Wang F
    Mol Cancer Ther; 2010 Aug; 9(8):2297-308. PubMed ID: 20682654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.
    Heath CH; Deep NL; Beck LN; Day KE; Sweeny L; Zinn KR; Huang CC; Rosenthal EL
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):982-90. PubMed ID: 23525846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical imaging predicts tumor response to anti-EGFR therapy.
    Helman EE; Newman JR; Dean NR; Zhang W; Zinn KR; Rosenthal EL
    Cancer Biol Ther; 2010 Jul; 10(2):166-71. PubMed ID: 20505368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
    Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
    J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
    Zhou Q; van den Berg NS; Kang W; Pei J; Nishio N; van Keulen S; Engelen MA; Lee YJ; Hom M; Vega Leonel JCM; Hart Z; Vogel H; Cayrol R; Martin BA; Roesner M; Shields G; Lui N; Gephart MH; Raymundo RC; Yi G; Granucci M; Grant GA; Li G; Rosenthal EL
    J Nucl Med; 2022 Nov; 63(11):1693-1700. PubMed ID: 35332092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
    Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
    Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.
    Kruser TJ; Armstrong EA; Ghia AJ; Huang S; Wheeler DL; Radinsky R; Freeman DJ; Harari PM
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):534-42. PubMed ID: 18793955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.
    Niu G; Sun X; Cao Q; Courter D; Koong A; Le QT; Gambhir SS; Chen X
    Clin Cancer Res; 2010 Apr; 16(7):2095-105. PubMed ID: 20215534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.
    Fakurnejad S; van Keulen S; Nishio N; Engelen M; van den Berg NS; Lu G; Birkeland A; Baik F; Colevas AD; Rosenthal EL; Martin BA
    Oral Oncol; 2019 Oct; 97():50-55. PubMed ID: 31421471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.
    Sweeny L; Prince A; Patel N; Moore LS; Rosenthal EL; Hughley BB; Warram JM
    Laryngoscope; 2016 Dec; 126(12):E387-E395. PubMed ID: 27576611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
    Ferris RL; Geiger JL; Trivedi S; Schmitt NC; Heron DE; Johnson JT; Kim S; Duvvuri U; Clump DA; Bauman JE; Ohr JP; Gooding WE; Argiris A
    Ann Oncol; 2016 Dec; 27(12):2257-2262. PubMed ID: 27733374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
    Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
    Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.
    van Dijk LK; Yim CB; Franssen GM; Kaanders JH; Rajander J; Solin O; Grönroos TJ; Boerman OC; Bussink J
    Contrast Media Mol Imaging; 2016; 11(1):65-70. PubMed ID: 26242487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
    Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
    Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma.
    Zaks O; Gaber D; Ben-Yaakov K; Sharvit-Bader M; Goz A; Rotfogel Z; Ish-Shalom S; Kesler E; Yosepovich A; Leiba H; Jager MJ; Marcovich AL; Aharoni-Simon M
    Exp Eye Res; 2021 Mar; 204():108431. PubMed ID: 33406396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.